Intravenous immunoglobulin in two children with Guillain-Barré syndrome

L. D. Notarangelo; M. Duse; S. Tiberti; B. Guarneri; A. Brunori; A. Negrini; A. G. Ugazio

doi:10.1007/BF01956757

Intravenous immunoglobulin in two children with Guillain-Barré syndrome

L. D. Notarangelo, M. Duse, S. Tiberti, B. Guarneri, A. Brunori, A. Negrini, A. G. Ugazio

Ospedale Pediatrico Bambino Gesu

Research output: Contribution to journal › Article

Abstract

Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.

Original language	English
Pages (from-to)	372-374
Number of pages	3
Journal	European Journal of Pediatrics
Volume	152
Issue number	4
DOIs	https://doi.org/10.1007/BF01956757
Publication status	Published - Apr 1993

Fingerprint

Keywords

Guillain-Barrè syndrome
Intravenous immunoglobulin

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Cite this

Notarangelo, L. D., Duse, M., Tiberti, S., Guarneri, B., Brunori, A., Negrini, A., & Ugazio, A. G. (1993). Intravenous immunoglobulin in two children with Guillain-Barré syndrome. European Journal of Pediatrics, 152(4), 372-374. https://doi.org/10.1007/BF01956757

@article{3a0bb179968e4fcf9d807dc8e31bcc9c,

title = "Intravenous immunoglobulin in two children with Guillain-Barr{\'e} syndrome",

abstract = "Two children with Guillain-Barr{\`e} syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barr{\`e} syndrome.",

keywords = "Guillain-Barr{\`e} syndrome, Intravenous immunoglobulin",

author = "Notarangelo, {L. D.} and M. Duse and S. Tiberti and B. Guarneri and A. Brunori and A. Negrini and Ugazio, {A. G.}",

year = "1993",

month = apr

doi = "10.1007/BF01956757",

language = "English",

volume = "152",

pages = "372--374",

journal = "European Journal of Pediatrics",

issn = "0340-6199",

publisher = "Springer Berlin Heidelberg",

number = "4",

}

TY - JOUR

T1 - Intravenous immunoglobulin in two children with Guillain-Barré syndrome

AU - Notarangelo, L. D.

AU - Duse, M.

AU - Tiberti, S.

AU - Guarneri, B.

AU - Brunori, A.

AU - Negrini, A.

AU - Ugazio, A. G.

PY - 1993/4

Y1 - 1993/4

N2 - Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.

AB - Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.

KW - Guillain-Barrè syndrome

KW - Intravenous immunoglobulin

UR - http://www.scopus.com/inward/record.url?scp=0027477763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027477763&partnerID=8YFLogxK

U2 - 10.1007/BF01956757

DO - 10.1007/BF01956757

M3 - Article

C2 - 8482293

AN - SCOPUS:0027477763

VL - 152

SP - 372

EP - 374

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 4

ER -

Access to Document

10.1007/BF01956757